Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Johannes, Hüsing"'
Autor:
Kevin Claaßen, Madeleine Karpinski, Hiltraud Kajüter, Johannes Hüsing, Lennart Möller, Ina Wellmann, Viktor Grünwald, Boris Hadaschik, Peter Albers, Andreas Stang
Publikováno v:
BMC Urology, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The crude mortality rate and the lifetime mortality risk from prostate cancer in Germany are above international average. However age-standardised mortality and years of life lost per capita from prostate cancer are declining. Thi
Externí odkaz:
https://doaj.org/article/c63f78473323475196a6089bc91729ea
Autor:
Phillip Knebel, Markus W Büchler, Markus K Diener, Felix J Hüttner, André L Mihaljevic, Oliver Strobel, Gauthier Bouche, Johannes Hüsing
Publikováno v:
BMJ Open, Vol 10, Iss 9 (2020)
Externí odkaz:
https://doaj.org/article/1023d7d9b97c4dfc92e2270d7de76a92
Autor:
Phillip Knebel, Markus W Büchler, Markus K Diener, Felix J Hüttner, André L Mihaljevic, Oliver Strobel, Gauthier Bouche, Johannes Hüsing
Publikováno v:
BMJ Open, Vol 10, Iss 9 (2020)
Externí odkaz:
https://doaj.org/article/9575ce61f51c4f65b38ffec971b9d983
Autor:
Tobias Forster, Clara Köhler, Melissa Dorn, Matthias Felix Häfner, Nathalie Arians, Laila König, Semi Ben Harrabi, Ingmar Schlampp, Fabian Weykamp, Eva Meixner, Kristin Lang, Vanessa Heinrich, Nicola Weidner, Johannes Hüsing, Markus Wallwiener, Michael Golatta, André Hennigs, Jörg Heil, Holger Hof, David Krug, Jürgen Debus, Juliane Hörner-Rieber
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics.
Autor:
Wolfgang Wick, Guido Reifenberger, Johannes Hüsing, Spyros Kollias, Peter Vajkoczy, Jürgen Meixensberger, Guido Nikkhah, Josef Pichler, Krisztian Homicsko, Roger Stupp, Roland Goldbrunner, Christine Marosi, Uwe Schlegel, Jörg C. Tonn, Michael Platten, Oliver Bähr, Ralf Ketter, Hans-Georg Wirsching, Michael C. Sabel, Ulrich Herrlinger, Peter Hau, Oliver Schnell, Antje Wick, Joachim P. Steinbach, Jörg Felsberg, Bärbel Kästner, Ghazaleh Tabatabai, Michael Weller
Purpose: Rechallenge with temozolomide (TMZ) at first progression of glioblastoma after temozolomide chemoradiotherapy (TMZ/RT→TMZ) has been studied in retrospective and single-arm prospective studies, applying temozolomide continuously or using 7/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddb706bb674b698fa144ace5e5df2087
https://doi.org/10.1158/1078-0432.c.6523838
https://doi.org/10.1158/1078-0432.c.6523838
Autor:
Wolfgang Wick, Guido Reifenberger, Johannes Hüsing, Spyros Kollias, Peter Vajkoczy, Jürgen Meixensberger, Guido Nikkhah, Josef Pichler, Krisztian Homicsko, Roger Stupp, Roland Goldbrunner, Christine Marosi, Uwe Schlegel, Jörg C. Tonn, Michael Platten, Oliver Bähr, Ralf Ketter, Hans-Georg Wirsching, Michael C. Sabel, Ulrich Herrlinger, Peter Hau, Oliver Schnell, Antje Wick, Joachim P. Steinbach, Jörg Felsberg, Bärbel Kästner, Ghazaleh Tabatabai, Michael Weller
Supplementary Figure 1. MMSE assessment at study entry, during treatment, and at follow-up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81734b446a09a69a3d09768408e5dfac
https://doi.org/10.1158/1078-0432.22458128.v1
https://doi.org/10.1158/1078-0432.22458128.v1
Autor:
Wolfgang Wick, Guido Reifenberger, Johannes Hüsing, Spyros Kollias, Peter Vajkoczy, Jürgen Meixensberger, Guido Nikkhah, Josef Pichler, Krisztian Homicsko, Roger Stupp, Roland Goldbrunner, Christine Marosi, Uwe Schlegel, Jörg C. Tonn, Michael Platten, Oliver Bähr, Ralf Ketter, Hans-Georg Wirsching, Michael C. Sabel, Ulrich Herrlinger, Peter Hau, Oliver Schnell, Antje Wick, Joachim P. Steinbach, Jörg Felsberg, Bärbel Kästner, Ghazaleh Tabatabai, Michael Weller
Supplementary Tables 1-7. Supplementary Table 1. Safety and tolerability. Supplementary Table 2. Outcome by MGMT promoter methylation status and treatment arm. Supplementary Table 3. Outcome by interval from last TMZ administration and MGMT promoter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de145f940886e3a0a42ea056a6daa678
https://doi.org/10.1158/1078-0432.22458125.v1
https://doi.org/10.1158/1078-0432.22458125.v1
Autor:
Maximilian Schultheiss, Florian Härtig, Martin S Spitzer, Nicolas Feltgen, Bernhard Spitzer, Johannes Hüsing, André Rupp, Ulf Ziemann, Karl U Bartz-Schmidt, Sven Poli
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0198114 (2018)
BACKGROUND:No evidence-based therapy exists for non-arteritic central retinal artery occlusion (NA-CRAO). Retinal ischemic tolerance is low; irreversible damage occurs within four hours of experimental NA-CRAO. In previous randomized trials evaluatin
Externí odkaz:
https://doaj.org/article/acaf8664c573482aa156f9670bf345a8
Autor:
Ingmar Schlampp, Juliane Hörner-Rieber, Clara Köhler, Matthias F. Häfner, Semi Harrabi, Eva Meixner, Tobias Forster, Jürgen Debus, N. Weidner, Adriane Hommertgen, Christof Sohn, Holger Hof, Vanessa Heinrich, David Krug, Michael Golatta, Johannes Hüsing, Laila König, Nathalie Arians, Jörg Heil
Publikováno v:
Radiotherapy and Oncology. 163:165-176
Background We recently published 2-year results of the prospective, randomized IMRT-MC2 trial, showing non-inferior local control and cosmesis in breast cancer patients after conventionally fractionated intensity-modulated radiotherapy with simultane
Autor:
Johannes Hüsing
Publikováno v:
Journal of Statistical Software, Vol 16, Iss 1, Pp 1-17 (2006)
A modification of an accept-and-reject algorithm to sample from a set of restricted permutations is proposed. By concentrating on a special class of matrices obtained by restriction of the permutation in time, assuming the objects to be permuted to b
Externí odkaz:
https://doaj.org/article/9ca2365fba9741e9b9a5d9b195290d0c